Patents by Inventor Mark A. DeCoster

Mark A. DeCoster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electromagnetic probe device
    Patent number: 7763175
    Abstract: The invention is an electromagnetic probe used in conjunction with a ferrofluid containng M particles. The electromagnetic probe is used to steer M-particles to a desired location, or use the M particles for mixing the ferrofluid. The probe can be used in conjunction with a microscope, a micromanipulator, a catheter or endoscope.
    Type: Grant
    Filed: May 17, 2005
    Date of Patent: July 27, 2010
    Assignee: The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Mark A. DeCoster, Nicolas G. Bazan
  • Compositions having neuroprotective and analgesic activity
    Patent number: 6410537
    Abstract: Compounds of the formula: wherein R1 and R2 are alkyl of 1-8 carbons have been shown to have both neuroprotective and analgesic activities. The compounds of the invention may be used in treatment of conditions that would normally result in neuronal damage, including those arising on account of cerebral ischemia/hypoxia or increase in intracranial pressure such as neoplasms, stroke, meningitis or trauma and for treatment of pain. Compositions of the invention can also be useful for treatment of toxin-related damage such as drug over-dose or exposure to toxins in the environment.
    Type: Grant
    Filed: April 3, 2000
    Date of Patent: June 25, 2002
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Frank C. Tortella, Mark A. DeCoster, Kenner C. Rice, Sylvia N. Calderon
  • Compositions having neuroprotective and analgesic activity
    Patent number: 6046200
    Abstract: Compounds of the formula: ##STR1## wherein R.sup.1 and R.sup.2 are alkyl of 1-8 carbons have been shown to have both neuroprotective and analgesic activities. The compounds of the invention may be used in treatment of conditions that would normally result in neuronal damage, including those arising on account of cerebral ischemia/hypoxia or increase in intracranial pressure such as neoplasms, stroke, meningitis or trauma. Compositions of the invention can also be useful for treatment of toxin-related damage such as drug over-dose or exposure to toxins in the environment.
    Type: Grant
    Filed: January 20, 1998
    Date of Patent: April 4, 2000
    Assignees: The United States of America as represented by the Secretary of the Army, The United States of America as represented by the Department of Health and Human Services
    Inventors: Frank C. Tortella, Mark A. DeCoster, Kenner C. Rice, Sylvia N. Calderon